Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BIMERVAX + Fluad Tetra
- Development stage
- Unknown
- Lead developer
- HIPRA Human Health
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
BIMERVAX + SIIV refers to the co-administration of BIMERVAX, a recombinant protein COVID-19 vaccine developed by HIPRA, and a Seasonal Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine (SIIV), specifically Fluad Tetra. BIMERVAX utilizes a recombinant protein homodimer of the SARS-CoV-2 spike protein receptor-binding domain (RBD) combined with a squalene-based adjuvant. Fluad Tetra is a quadrivalent inactivated influenza vaccine containing MF59 adjuvant. This combination regimen is evaluated in clinical trials to assess the safety and immunogenicity of simultaneous administration in elderly populations (aged 65 and older) who are already fully vaccinated against COVID-19, aiming to streamline immunization schedules for seasonal respiratory pathogens.
- Brand names
- Fluad Tetra
- Other names
- BIMERVAX + SIIVPHH-1V + SIIV
02
Targets
SARS-CoV-2 spikeHA (Hemagglutinin)
Beyond the preview
Go deeper on BIMERVAX + Fluad Tetra.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIMERVAX + Fluad Tetra.